RECAP U.S. stocks advanced on Monday, building off a record finish ahead of the ramping up of fourth-quarter earnings season. The$道琼斯指数(.DJI.US)$rose 138 points, or 0.26%, to 38,000. The$标普500指数(.SPX.US)$was up 10 points, or 0.22%, at 4,850. The$纳斯达克综合指数(.IXIC.US)$advanced 49 points, or 0.32%, to 15,360. While the S&P 500 finally returned to record territory on Friday, skeptic...
28
3
7
举报
BelleWeather :
GILD is down .03%, or two cents. Two pennies. That is not a remarkable fall.
After two major indexes reached all-time highs, pharmaceutical stocks for companies in drug trials were caught up in the energy and rocketed forward. The largest gainers were$Spyre Therapeutics(SYRE.US)$, up 26% Monday morning, and$Gyre Therapeutics(GYRE.US)$+10%. Spyre felt the positive pressure from fresh buy ratings by analysts like Stifel.$Ginkgo Bioworks(DNA.US)$also roase 9%, despite a new sell rating from Goldman Sachs. But monday morning was not al...
4
1
举报
103398487 :
thanks..is syre a good buy today at current price of 20.640 ?
AmyNic楼主potsy52:
Eventually, it's going to do something. It's green for the week so far so that's showing some good signs.If we close the week green we may see a reversal very soon.
BelleWeather : GILD is down .03%, or two cents. Two pennies. That is not a remarkable fall.
71731595 BelleWeather: Remarkable
DudeThatsDerpy : Sheesh. The spelling errors in this article make it feel less reliable.